Chiron Behring Vaccines Private Limited, a active private limited company, was established on 07 October 1997 in Bhor, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24230PN1997PTC222142. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹10.00 Cr.
Formerly known as Chiron Behring Vaccines Limited. It upholds a compliant status. Employing 187 professional, Its leadership includes Raches Virendradev Ella (Director), Sai Prasad Devarajulu (Whole-Time Director). Past directors included Kaizad Adi Hazari, Rishikesh Satish Jaiwant, Christophe Germain. It holds ₹0.42 M open charges and ₹2.46 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No27 (Gatno.136) At Manjari Khurd Village, Taluka Haveli,, Bhor, Maharashtra, 412205.
U24230PN1997PTC222142
222142
07 October 1997
₹10.00 Cr
₹10.00 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Chiron Behring Vaccines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raches Virendradev Ella | Director | 31 Aug 2019 | Current |
| Sai Prasad Devarajulu | Whole-Time Director | 01 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2017 | Past |
| Pramod Abcsdd | Director | 05 Jan 2019 | Past |
| Pramod Abcsdd | Nominee Director | 01 Oct 2009 | Past |
| Pramod Abcsdd | Nominee Director | 08 Jul 2009 | Past |
| Pramod Abcsdd | Alternate Director | 01 Jul 2013 | Past |
| Pramod Abcsdd | Alternate Director | 11 Dec 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chiron Behring Vaccines Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 53.53% decrease. The company also saw a substantial fall in profitability, with a 28187.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Chiron Behring Vaccines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹419,500.00
₹24,590,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2020 | Others | ₹0.42 M | Open |
| 11 Aug 2020 | Others | ₹4.59 M | Satisfied |
| 22 Feb 1999 | Bank Of America Natis Trust & Saving Assoen | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Chiron Behring Vaccines has a workforce of 187 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chiron Behring Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiron Behring Vaccines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chiron Behring Vaccines Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Chiron Behring Vaccines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Yedlapati Kurana Priyadarshini was appointed as a Company Secretary was appointed as a Company Secretary on 26 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity A charge registered on 11 Aug 2020 via Charge ID 100363260 with Others was fully satisfied on 29 Nov 2021. was completed.
Progress on A charge with Others amounted to Rs. 0.04 Cr with Charge ID 100363261 was registered on 11 Aug 2020. was documented.
Progress on A charge with Others amounted to Rs. 0.46 Cr with Charge ID 100363260 was registered on 11 Aug 2020. was documented.
The CIN of Chiron Behring Vaccines Private Limited is U24230PN1997PTC222142.
Chiron Behring Vaccines Private Limited is headquartered at Survey No27 (Gatno.136) At Manjari Khurd Village, Taluka Haveli,, Bhor, Maharashtra, 412205.
Chiron Behring Vaccines Private Limited was incorporated on 07 October 1997.
The current directors of Chiron Behring Vaccines Private Limited are
The primary industry of Chiron Behring Vaccines Private Limited is Manufacturing.
Chiron Behring Vaccines Private Limited is unlisted.
The authorized capital of Chiron Behring Vaccines Private Limited is ₹10.00 Cr, and the paid-up capital is ₹10.00 Cr.
The compliance status of Chiron Behring Vaccines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX